Corticomedullary mixed adrenal tumor: Case report and literature review

Endocrine Journal

Volumn 56, Issue 6, 2009, Pages 817-824

  Alexandraki, Krystallenia I ^a,c   Michail, Othon P ^a   Nonni, Afrodite ^b   Diamantis, Dimitrios ^a   Giannopoulou, Ioanna ^b   Kaltsas, Gregory A ^a   Tseleni Balafouta, Sofia ^b   Syriou, Vassiliki ^a   Michail, Panayiotis O ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cortical adenoma; Corticomedullary mixed adrenal tumor; Phaeochromocytoma

Indexed keywords

HYDROCORTISONE;

ADRENAL GLAND; ADRENAL INCIDENTALOMA; ADRENAL TUMOR; ADRENALECTOMY; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOMEDULLARY MIXED ADRENAL TUMOR; ENDOCRINE FUNCTION TEST; EXCISION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MIXED TUMOR; PHEOCHROMOCYTOMA; SPIGELIAN HERNIA;

ADENOMA; ADRENAL GLAND NEOPLASMS; AGED; FEMALE; HERNIA, ABDOMINAL; HUMANS; INCIDENTAL FINDINGS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350029197     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-010     Document Type: Article

References (31)

1. Alexandraki KI, Grossman AB. (2008) Adrenal incidentalomas: 'the rule of four'. Clinical Medicine 8: 201-204.
2. Prinz RA, Brooks MH, Churchill R, Graner JL, Lawrence AM, Paloyan E, Sparagana M. (1982) Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required? The Journal of the American Medical Association 248: 701-704.
3. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS. (2003) Management of the clinically inapparent adrenal mass ('incidentaloma'). Annals of Internal Medicine 138: 424-429. (Pubitemid 36262654)
4. Wieneke JA, Thompson LD, Heffess CS. (2001) Corticomedullary mixed tumor of the adrenal gland. Annals of Diagnostic Pathology 5: 304-308.
5. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine Reviews 25: 309-340. (Pubitemid 38528713)
6. Young WF Jr. (2007) Clinical practice. The incidentally discovered adrenal mass. New England Journal of Medicine 356: 601-610.
7. Skandalakis PN, Zoras O, Skandalakis JE, Mirilas P. (2006) Spigelian hernia: surgical anatomy, embryology, and technique of repair. The American Surgeon 72: 42-48. (Pubitemid 351837723)
8. Trainers PT, Besser M. (1995) Corticosteroid cover for surgery. In: The Bart's Endocrine Protocols, Section 2, pp 67-68. eds Churchilll Livingstone. Edinburgh London Madrid Melbourne New York and Tokyo.
9. Sasano H, Koch CA, Young Jr WF, Giordano TJ, Chrousos GP, Kawashima A. (2004) Adrenal cortical adenoma. World Health Organization Classification of tumors. In: Pathology and Genetics. Tumors of Endocrine Organs. Ronald A. Dellelis, Ricardo V. Lloyd, Philipp U. Heitz, Charis Eng, pp 143-146. Eds IARC Press, Lyon.
10. Mathison DA, Waterhouse CA. (1969) Cushing's syndrome with hypertensive crisis and mixed adrenal cortical adenoma-pheochromocytoma (corticomedullary adenoma). The American Journal of Medicine 47: 635-641.
11. Akai H, Sanoyama K, Namai K, Miura Y, Murakami O, Hanew K, Sasaki H, Kimura N, Takahashi K, Sasano N, et al. (1993) A case of adrenal mixed tumor of pheochromocytoma and adrenocortical adenoma presenting diabetes mellitus and hypertension. Nippon Naibunpi Gakkai Zasshi 69: 659-669.
12. Ohta TI, Motoyama T, Imai T. (1995) Cortico-medullary mixed tumor (phaeochromocytoma and cortical adenoma) of the adrenal gland. Journal of Urological Pathology 3: 157-164.
13. Michal M, Havlicek F. (1996) Corticomedullary tumors of the adrenal glands. Report of two cases. Association of corticomedullary tumor with spindle cell sarcoma. Pathology, Research and Practice 192: 1082-1089. (Pubitemid 27065021)
14. Hu WL, Cao QY, He HX, L J, Li QR, Wang YL, Nie HB, Yang H, Huang XT, Zhu YS, Deng ZX, Wang W. (2002) Misdiagnosis of corticomedullary mixed pathological changes in adrenals: report of 4 cases. Di Yi Jun Yi Da Xue Xue Bao 22: 1145-1147.
15. Chu AY, LiVolsi VA, Fraker DL, Zhang PJ. (2003) Corticomedullary mixed tumor of the adrenal gland with concurrent adrenal myelolipoma. Archives of Pathology & Laboratory Medicine 127 e329-332.
16. Ma WY, Yang AH, Chang YH, Lin LY, Lin HD. (2007) Coexistence of Adrenal Cushing Syndrome and Pheochromocytoma in a "Corticomedullary Adenoma": A Case Report and Review of the Literature. Endocrinologist 17: 341-345.
17. Lee P, Bradbury RA, Sy J, Hughes L, Wong L, Falk G, Chen R. (2008) Phaeochromocytoma and mixed corticomedullary tumor - a rare cause of Cushing's syndrome and labile hypertension in a primigravid woman postpartum. Clinical Endocrinology (Oxf) 68: 492-494. (Pubitemid 351257847)
18. Delèvaux I, Cabane J, Picard O, Bénit C, Lebas J, Nordlinger B, de Saint-Maur P, Imbert JC. (1998) Mixed corticomedullary tumor. Presse Medicale 27: 1272-1274.
19. Bisceglia M, Nirchio V, Attino V, Di Cerbo A, Mantovani W, Pasquinelli G. (1998) "Black adenoma" associated with medullary nodular hyperplasia in the ipsilateral adrenal gland. Case report and review of the literature regarding "mixed" cortico-medullary pathology. Pathologica 90: 306-312.
20. LeCompte PM. (1944) Cushing's Syndrome with Possible Pheochromocytoma Report of a Case. The American Journal of Pathology 20: 689-707
21. DallaPria M, Barillari B, Patrone C. (1964) Cushing's syndrome and syndrome of medullary hyperfunction caused by adrenal adenoma. Archivio di Patologia e Clinica Medica 41: 99-114.
22. Carey RM, Varma SK, Drake CR Jr, Thorner MO, Kovacs K, Rivier J, Vale W. (1984) Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. New England Journal of Medicine 311 13-20.
23. Cope O, Labbe JP, Raker JW, Bland EF. (1952) Pheochromocytoma and adrenal cortical adenoma. Report of a case with both tumors and discussion of their relation. Journal of Clinical Endocrinology and Metabolism 12: 875-880.
24. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. (1998) Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocrine Reviews 19: 101-143. (Pubitemid 29114288)
25. Ishiguro H, Kim KT, Joh TH, Kim KS. (1993) Neuron-specific expression of the human dopamine beta-hydroxylase gene requires both the cAMP-response element and a silencer region. The Journal of Biological Chemistry 268: 17987-17994. (Pubitemid 23260316)
26. Evinger MJ, Ernsberger P, Regunathan S, Reis DJ. (1995) Regulation of phenylethanolamine N-methyltransferase gene expression by imidazoline receptors in adrenal chromaffin cells. Journal of Neurochemistry 65: 988-997.
27. Stachowiak MK, Rigual RJ, Lee PHK. (1998) Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferse mRNA levels in the sympathoadrenal system by the pituitary-adrenocortical axis. Brain Research 427: 275-286.
28. Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E. (2001) Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 86: 5301-5306. (Pubitemid 33070251)
29. Rosenzweig JL, Ferrannini E, Grundy SM, Haffner SM, Heine RJ, Horton ES, Kawamori R. (2008) Endocrine Society. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 93: 3671-3689.
30. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS (2007) International Symposium on Pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the first international Symposium. October 2005. Natural Clinical Practice. Endocrinology and Metabolism 3: 92-102
31. Gimenez-Roqueplo AP, Lehnert H, Mannelli M, Neumann H, Opocher G, Maher ER, Plouin PF (2006) European Network for the Study of Adrenal Tumours (ENS@T) Pheochromocytoma Working Group. Phaeochromocytoma, new genes and screening strategies. Clinical Endocrinology. 65: 699-705.